Early, Persistent Lymphopenia Is Associated With Prolonged Multiple Organ Failure and Mortality in Septic Children.

Area of Science:

• Pediatric critical care medicine
• Immunology
• Sepsis research

Background:

• Sepsis-associated immune suppression is a known factor in poor outcomes.
• Adult studies are exploring immune support therapies for sepsis.
• Data on immunomodulation in pediatric sepsis is limited.

Purpose of the Study:

• To investigate the association between early, persistent lymphopenia and outcomes in pediatric severe sepsis.
• To test the hypothesis that lymphopenia predicts worse outcomes in this population.

Main Methods:

• An observational cohort study was conducted in nine PICUs.
• Patients with severe sepsis were categorized based on early, persistent lymphopenia (absolute lymphocyte count < 1,000 cells/µL on 2 days between study days 0-5).
• The composite outcome assessed was prolonged multiple organ dysfunction syndrome (MODS) or PICU mortality.

Main Results:

• 38% of 401 pediatric severe sepsis patients had persistent lymphopenia.
• Persistent lymphopenia was associated with a significantly higher risk of prolonged MODS or PICU mortality (43% vs. 18%).
• Patients with lymphopenia showed impaired TNF-α response and elevated inflammatory markers.

Conclusions:

• Early, persistent lymphopenia in pediatric severe sepsis identifies patients at high risk for prolonged MODS or PICU mortality.
• This risk stratification supports the investigation of immunomodulatory therapies in this patient group.
• Further research is warranted to develop targeted treatments for pediatric sepsis based on immune status.